The Generation of an Engineered Interleukin-10 Protein With Improved Stability and Biological Function. (2020)
Attributed to:
Targeting the IL-33-inflammasome axis in therapy for cerebral malaria
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2020.01794
PubMed Identifier: 32849644
Publication URI: http://europepmc.org/abstract/MED/32849644
Type: Journal Article/Review
Volume: 11
Parent Publication: Frontiers in immunology
ISSN: 1664-3224